BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 31822509)

  • 1. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.
    Karkhanis V; Alinari L; Ozer HG; Chung J; Zhang X; Sif S; Baiocchi RA
    J Biol Chem; 2020 Jan; 295(5):1165-1180. PubMed ID: 31822509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
    Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
    J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad.
    Pal S; Yun R; Datta A; Lacomis L; Erdjument-Bromage H; Kumar J; Tempst P; Sif S
    Mol Cell Biol; 2003 Nov; 23(21):7475-87. PubMed ID: 14559996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1.
    Gao G; Dhar S; Bedford MT
    Nucleic Acids Res; 2017 May; 45(8):4359-4369. PubMed ID: 28115626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
    Chung J; Karkhanis V; Baiocchi RA; Sif S
    J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.
    Zhang X; Chen X; Lin J; Lwin T; Wright G; Moscinski LC; Dalton WS; Seto E; Wright K; Sotomayor E; Tao J
    Oncogene; 2012 Jun; 31(24):3002-3008. PubMed ID: 22002311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.
    Alinari L; Mahasenan KV; Yan F; Karkhanis V; Chung JH; Smith EM; Quinion C; Smith PL; Kim L; Patton JT; Lapalombella R; Yu B; Wu Y; Roy S; De Leo A; Pileri S; Agostinelli C; Ayers L; Bradner JE; Chen-Kiang S; Elemento O; Motiwala T; Majumder S; Byrd JC; Jacob S; Sif S; Li C; Baiocchi RA
    Blood; 2015 Apr; 125(16):2530-43. PubMed ID: 25742700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine methylation of translocated in liposarcoma (TLS) inhibits its binding to long noncoding RNA, abrogating TLS-mediated repression of CBP/p300 activity.
    Cui W; Yoneda R; Ueda N; Kurokawa R
    J Biol Chem; 2018 Jul; 293(28):10937-10948. PubMed ID: 29784880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression.
    Liu M; Yao B; Gui T; Guo C; Wu X; Li J; Ma L; Deng Y; Xu P; Wang Y; Yang D; Li Q; Zeng X; Li X; Hu R; Ge J; Yu Z; Chen Y; Chen B; Ju J; Zhao Q
    Theranostics; 2020; 10(10):4437-4452. PubMed ID: 32292506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between histone deacetylases and c-Myc in the transcriptional suppression of HPP1 in colon cancer.
    Wang J; Elahi A; Ajidahun A; Clark W; Hernandez J; Achille A; Hao JH; Seto E; Shibata D
    Cancer Biol Ther; 2014 Sep; 15(9):1198-207. PubMed ID: 24919179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
    Shailesh H; Siveen KS; Sif S
    J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 is transcriptionally down-regulated by ZO-2 via an E box and the transcription factor c-Myc.
    Huerta M; Muñoz R; Tapia R; Soto-Reyes E; Ramírez L; Recillas-Targa F; González-Mariscal L; López-Bayghen E
    Mol Biol Cell; 2007 Dec; 18(12):4826-36. PubMed ID: 17881732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
    Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B
    Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
    Duan H; Heckman CA; Boxer LM
    Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.
    Li Y; Chitnis N; Nakagawa H; Kita Y; Natsugoe S; Yang Y; Li Z; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
    Cancer Discov; 2015 Mar; 5(3):288-303. PubMed ID: 25582697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment.
    Fu M; Rao M; Bouras T; Wang C; Wu K; Zhang X; Li Z; Yao TP; Pestell RG
    J Biol Chem; 2005 Apr; 280(17):16934-41. PubMed ID: 15713663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas.
    Zhang X; Zhao X; Fiskus W; Lin J; Lwin T; Rao R; Zhang Y; Chan JC; Fu K; Marquez VE; Chen-Kiang S; Moscinski LC; Seto E; Dalton WS; Wright KL; Sotomayor E; Bhalla K; Tao J
    Cancer Cell; 2012 Oct; 22(4):506-523. PubMed ID: 23079660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CARM1-mediated methylation of protein arginine methyltransferase 5 represses human γ-globin gene expression in erythroleukemia cells.
    Nie M; Wang Y; Guo C; Li X; Wang Y; Deng Y; Yao B; Gui T; Ma C; Liu M; Wang P; Wang R; Tan R; Fang M; Chen B; He Y; Huang DCS; Ju J; Zhao Q
    J Biol Chem; 2018 Nov; 293(45):17454-17463. PubMed ID: 30257864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma.
    Holmes B; Benavides-Serrato A; Saunders JT; Landon KA; Schreck AJ; Nishimura RN; Gera J
    J Neurooncol; 2019 Oct; 145(1):11-22. PubMed ID: 31473880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine methylation regulates c-Myc-dependent transcription by altering promoter recruitment of the acetyltransferase p300.
    Tikhanovich I; Zhao J; Bridges B; Kumer S; Roberts B; Weinman SA
    J Biol Chem; 2017 Aug; 292(32):13333-13344. PubMed ID: 28652407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.